Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study

[1]  Wen Li,et al.  The COMT Genetic Factor Regulates Chemotherapy-Related Prospective Memory Impairment in Survivors With HER2−/+ Breast Cancer , 2022, Frontiers in Oncology.

[2]  Bryan D. Thompson,et al.  Inflammation, Attention, and Processing Speed in Patients with Breast Cancer before and after Chemotherapy. , 2022, Journal of the National Cancer Institute.

[3]  K. Saijo,et al.  Tumor-induced disruption of the blood-brain barrier promotes host death. , 2021, Developmental cell.

[4]  M. Flint,et al.  Tumour brain: Pretreatment cognitive and affective disorders caused by peripheral cancers , 2021, British journal of pharmacology.

[5]  H. Cohen,et al.  Protective Effects of APOE ε2 Genotype on Cognition in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study , 2021, JNCI cancer spectrum.

[6]  H. Cohen,et al.  Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living with Cancer Study. , 2021, Journal of the National Cancer Institute.

[7]  Zhong-hua Wang,et al.  JAK/STAT signaling pathway-mediated microRNA-181b promoted blood-brain barrier impairment by targeting sphingosine-1-phosphate receptor 1 in septic rats , 2020, Annals of translational medicine.

[8]  H. Cohen,et al.  Cognitive function prior to systemic therapy and subsequent well‐being in older breast cancer survivors: Longitudinal findings from the Thinking and Living with Cancer Study , 2020, Psycho-oncology.

[9]  Elizabeth A. Salerno,et al.  Embracing the complexity: Older adults with cancer-related cognitive decline-A Young International Society of Geriatric Oncology Position Paper. , 2020, Journal of geriatric oncology.

[10]  H. Cohen,et al.  Symptom burden among older breast cancer survivors: The Thinking and Living With Cancer (TLC) study , 2019, Cancer.

[11]  R. Noppens,et al.  Anesthesiology and cognitive impairment: a narrative review of current clinical literature , 2019, BMC Anesthesiology.

[12]  P. Ganz,et al.  Identifying Cancer-Related Cognitive Impairment Using the FACT-Cog Perceived Cognitive Impairment , 2019, JNCI cancer spectrum.

[13]  T. Ahles,et al.  Chemotherapy-Induced Cognitive Impairment Is Associated with Increased Inflammation and Oxidative Damage in the Hippocampus , 2019, Molecular Neurobiology.

[14]  H. Dhillon,et al.  Low dose aspirin blocks breast cancer-induced cognitive impairment in mice , 2018, PloS one.

[15]  Azeem Alam,et al.  Surgery, neuroinflammation and cognitive impairment , 2018, EBioMedicine.

[16]  J. VanMeter,et al.  Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  J. Root,et al.  Cognitive Effects of Cancer and Cancer Treatments. , 2018, Annual review of clinical psychology.

[18]  Bryan D. Thompson,et al.  Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy , 2018, Journal of Neuroimmunology.

[19]  P. White,et al.  Age exacerbates surgery-induced cognitive impairment and neuroinflammation in Sprague-Dawley rats: the role of IL-4 , 2017, Brain Research.

[20]  L. Minasian,et al.  Longitudinal assessment of cancer-related cognitive impairment (CRCI) up to six-months post-chemotherapy with multiple cognitive testing methods in 943 breast cancer (BC) patients and controls. , 2017 .

[21]  Theresa A. Koleck,et al.  Associations between pathologic tumor features and preadjuvant therapy cognitive performance in women diagnosed with breast cancer , 2017, Cancer medicine.

[22]  T. Ng,et al.  Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients , 2016, PloS one.

[23]  M. Bühner,et al.  Elucidating pretreatment cognitive impairment in breast cancer patients: the impact of cancer-related post-traumatic stress. , 2015, Journal of the National Cancer Institute.

[24]  B. McEwen,et al.  Cancer, coping, and cognition: a model for the role of stress reactivity in cancer‐related cognitive decline , 2015, Psycho-oncology.

[25]  R. Sankowski,et al.  Systemic Inflammation and the Brain: Novel Roles of Genetic, Molecular, and Environmental Cues as Drivers of Neurodegeneration , 2015, Front. Cell. Neurosci..

[26]  Jan Ramon,et al.  A new ensemble coevolution system for detecting HIV-1 protein coevolution , 2015, Biology Direct.

[27]  L. Mackenzie,et al.  Chemobrain Experienced by Breast Cancer Survivors: A Meta-Ethnography Study Investigating Research and Care Implications , 2014, PloS one.

[28]  F. Eustache,et al.  Baseline cognitive functions among elderly patients with localised breast cancer. , 2014, European journal of cancer.

[29]  A. Saykin,et al.  Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity? , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  M. Watanabe,et al.  Molecular Markers for Breast Cancer: Prediction on Tumor Behavior , 2014, Disease markers.

[31]  J. Carpenter,et al.  Impact of perceived cognitive impairment in breast cancer survivors. , 2013, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[32]  E. Zee,et al.  Thinking through postoperative cognitive dysfunction: How to bridge the gap between clinical and pre-clinical perspectives , 2012, Brain, Behavior, and Immunity.

[33]  T. Ahles,et al.  International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. , 2011, The Lancet. Oncology.

[34]  K. Possinger,et al.  Association of IL-6, Hypothalamus-Pituitary-Adrenal Axis Function, and Depression in Patients With Cancer , 2010, Integrative cancer therapies.

[35]  Carmen Birchmeier,et al.  ErbB receptors and the development of the nervous system. , 2009, Experimental cell research.

[36]  Andrew J. Saykin,et al.  Cognitive function in breast cancer patients prior to adjuvant treatment , 2008, Breast Cancer Research and Treatment.

[37]  Andrew J. Saykin,et al.  Candidate mechanisms for chemotherapy-induced cognitive changes , 2007, Nature Reviews Cancer.

[38]  M. Albitar,et al.  Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome , 2005, Cancer.

[39]  L. Radloff.  The CES-D Scale , 1977 .

[40]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[41]  OUP accepted manuscript , 2022, Journal of the National Cancer Institute.

[42]  Salma K. Marani,et al.  University of Groningen Cognitive Impairment in Men With Testicular Cancer Prior to Adjuvant Therapy , 2017 .

[43]  C. Spielberger,et al.  Manual for the State-Trait Anxiety Inventory , 1970 .

[44]  L. Radloff.  The CES-D Scale: A Self-Report Depression Scale for Research in the General Population — Source link , 2022 .